| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/24/2008 | WO2008046798A1 Isoindol derivatives as ep4 receptor agonists |
| 04/24/2008 | WO2008046796A2 Use of c10-c14-alkane-1,2-diols in the preparation of a composition for the prophylaxis and/or treatment of dermatophyte infections |
| 04/24/2008 | WO2008046757A1 Aminomethyl-4-imidazoles |
| 04/24/2008 | WO2008046756A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
| 04/24/2008 | WO2008046657A1 Triazines and their use as inhibitors of metalloproteinases |
| 04/24/2008 | WO2008046647A1 VR1 RECEPTOR LIGANDS AND µ OPIOID RECEPTOR LIGANDS FOR THE TREATMENT OF PAIN |
| 04/24/2008 | WO2008046617A1 Escitalopram and solid pharmaceutical composition comprising the same |
| 04/24/2008 | WO2008046606A2 Topical composition for the treatment of eczema |
| 04/24/2008 | WO2008046598A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE β2 ADRENERGIC RECEPTOR |
| 04/24/2008 | WO2008046582A1 Substituted tetrahydropyrrolopyrazine compounds having affinity with the kcnq2/3 k+ channel and use thereof in medicaments |
| 04/24/2008 | WO2008046581A2 Substituted tetrahydropyrrolopyrazine compounds and use thereof in medicaments |
| 04/24/2008 | WO2008046576A1 Use of glucocorticoid antagonists in vaccination |
| 04/24/2008 | WO2008046573A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators |
| 04/24/2008 | WO2008046559A1 USE OF ESTRADIOL VALERATE OR 17β-ESTRADIOL IN COMBINATION WITH DIENOGEST FOR ORAL THERAPY FOR MAINTAINING AND/OR INCREASING THE FEMALE LIBIDO |
| 04/24/2008 | WO2008046538A2 Non-steroid antiphlogistics against coughing |
| 04/24/2008 | WO2008046527A1 Acylaminopyrazoles for treating cardiovascular diseases |
| 04/24/2008 | WO2008046521A1 Preparation for oral administration (ii) |
| 04/24/2008 | WO2008046497A1 3 -amino-imidazo [1,2 -a] pyridine derivatives having an sglt1 and sglt2 inhibiting action, for treating type 1 and type 2 diabetes |
| 04/24/2008 | WO2008046357A1 Aqueous solution containing sodium pyruvate, preparation method and use thereof |
| 04/24/2008 | WO2008046285A1 The uses of the carboxy-amido-triazole compounds and salts thereof |
| 04/24/2008 | WO2008046242A1 The novel quinazoline derivatives,preparation methods and uses thereof |
| 04/24/2008 | WO2008046230A1 Phospholipid receptors as targets for enhancing drug permeability to selected tissues |
| 04/24/2008 | WO2008046226A1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 04/24/2008 | WO2008046216A1 Kinase inhibitors and uses thereof |
| 04/24/2008 | WO2008046202A1 USE OF PYπDOXAL-5'-PHOSPHATE FOR IMPROVING THE IMMUNE RESPONSE AND TREATMENT AND PREVENTION OF POST-OPERATIVE INFECTIONS |
| 04/24/2008 | WO2008046162A1 Inhibition of degradation of extracellular matrix |
| 04/24/2008 | WO2008046160A1 Assay for the detection of biomarkers associated with pregnancy related conditions |
| 04/24/2008 | WO2008046155A1 Methods for regulating glucose homeostasis and agents therefor |
| 04/24/2008 | WO2008046135A1 Novel anxiolytic compounds |
| 04/24/2008 | WO2008031017A9 Supramolecular metallic complexes exhibiting both dna binding and photocleavage |
| 04/24/2008 | WO2008030591A3 Peham dendrimers as excipients |
| 04/24/2008 | WO2008030512A3 Polystyrene sulfonate polymer tablets, their preparation and use |
| 04/24/2008 | WO2008029096A3 P53 activating benzoyl urea and benzoyl thiourea compounds |
| 04/24/2008 | WO2008027600A3 Imatinib compositions |
| 04/24/2008 | WO2008025170B1 Selective glycosidase inhibitors and uses thereof |
| 04/24/2008 | WO2008024765A3 Therapeutic substituted thiazolidinones, oxazolidinones, and related compounds |
| 04/24/2008 | WO2008023336A3 Matrix metalloproteinase inhibitors |
| 04/24/2008 | WO2008023184A3 Solid dosage form |
| 04/24/2008 | WO2008021518A3 Crystalline forms of tiagabine hydrochloride and processes for the preparation of amorphous tiagabine hydrochloride |
| 04/24/2008 | WO2008020456A3 Pyrrolo[2,1-c][1,4]benzodiazepine hybrids and a process for the preparation thereof |
| 04/24/2008 | WO2008020206A3 Fused thiophene derivatives as mek inhibitors |
| 04/24/2008 | WO2008019967A3 Phenyl, pyridine and quinoline derivatives |
| 04/24/2008 | WO2008019070A3 Pharmaceutical compositions of trospium for treating smooth muscle hyperactivity disorders |
| 04/24/2008 | WO2008016660A3 Imidazoacridine compounds for treating leukemias |
| 04/24/2008 | WO2008015374A3 Protein free formula |
| 04/24/2008 | WO2008015139A3 Inhibitors of zinc proteases thioaryl substituted and their use |
| 04/24/2008 | WO2008014299A3 Use of an alpha2-agonist composition for the treatment of hyperlipidemia |
| 04/24/2008 | WO2008012695A3 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells |
| 04/24/2008 | WO2008012534A3 Retinoids and small molecules as nrf2 antagonists for use in the treatment of diseases associated with abnormal cell proliferation |
| 04/24/2008 | WO2008011116A3 Aza-peptide protease inhibitors |
| 04/24/2008 | WO2008011080A3 Benzo(d) isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine |
| 04/24/2008 | WO2008009638A3 New indications for direct thrombin inhibitors in the cardiovascular field |
| 04/24/2008 | WO2008009415A3 4-heteroaryl-substituted 1-aminocyclohexane-1- and cyclohexene-1-derivatives having effects on the opiod receptor system |
| 04/24/2008 | WO2008008537A3 Combi) compositions for the treatment of mucormycosis. comprising iron chelator and antifungal agent |
| 04/24/2008 | WO2008008286A3 Substituted pyrazoles as ghrelin receptor antagonists |
| 04/24/2008 | WO2008006979B1 Process for preparing diaminophenothiazinium compounds |
| 04/24/2008 | WO2008006224A8 Medicagenic acid saponin and uses thereof |
| 04/24/2008 | WO2008005519A3 Novel pyridazine compound and use thereof |
| 04/24/2008 | WO2007150075A3 Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
| 04/24/2008 | WO2007149935A3 Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator |
| 04/24/2008 | WO2007149730A3 Inhibitors of akt (protein kinase b) |
| 04/24/2008 | WO2007149285A3 Method of improved diuresis in individuals with impaired renal function |
| 04/24/2008 | WO2007146416B1 Glucan preparations |
| 04/24/2008 | WO2007146202A3 Succinate salts of 6-methoxy-8-[4-(1-(5-fluoro)-quinolin-8-yl-piperidin-4-yl)-piperazin-1-yl]-quinoline and crystalline forms thereof |
| 04/24/2008 | WO2007144082A3 Combination antihypertensive wafer |
| 04/24/2008 | WO2007144080A3 Combination antidepressants wafer |
| 04/24/2008 | WO2007138485A3 Ppar modulators |
| 04/24/2008 | WO2007136858A3 Small molecule inhibitors of stat3 with anti-tumor activity |
| 04/24/2008 | WO2007133800A3 Toll-like receptor (tlr) stimulation for ocular angiogenesis and macular degeneration |
| 04/24/2008 | WO2007127487A3 Materials and methods for reducing inflammation by inhibition of the atrial natriuretic peptide receptor |
| 04/24/2008 | WO2007118717A3 METHOD FOR PREPARING 4-[17β-METHOXY-17α-METHOXYMETHYL-3-OXOESTRA-4,9-DIEN-11β-YL]BENZALDEHYDE (E)-OXIME (ASOPRISNIL) |
| 04/24/2008 | WO2007118135A3 Methods for prevention and treatment of conditions arising from local estrogen deficiency |
| 04/24/2008 | WO2007112754A3 Pharmaceutical compositions comprising anti-mirna antisense oligonucleotides |
| 04/24/2008 | WO2007110778A3 Mucosal bioadhesive slow release carrier for delivering active principles |
| 04/24/2008 | WO2007109799A3 Polymorphs of eszopiclone malate |
| 04/24/2008 | WO2007109677A3 A novel method of protecting islet cells from apoptosis during the donor harvesting process |
| 04/24/2008 | WO2007109236A3 Microrna fingerprints during human megakaryocytopoiesis |
| 04/24/2008 | WO2007108947A3 Nitrofuran compounds for the treatment of cancer and angiogenesis |
| 04/24/2008 | WO2007100671A3 Compositions and methods for inducing bone growth and inhibiting bone loss |
| 04/24/2008 | WO2007095293A3 Plasma from vitiligo patients for treatment of melanoma |
| 04/24/2008 | WO2007088489A3 Pharmaceutical composition containing a central opioid agonist, a central opioid antagonist, and a peripheral opioid antagonist, and method for making the same |
| 04/24/2008 | WO2007084865A3 RNA INTERFERENCE MEDIATED INHIBITION OF B7-H1 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/24/2008 | WO2007084162A3 Sirtuin inhibiting compounds |
| 04/24/2008 | WO2007081571A3 Cetp inhibitors |
| 04/24/2008 | WO2007078820A3 Methylmaleimidyl polymer derivatives |
| 04/24/2008 | WO2007075870A3 Processes for taxane derivatives and intermediates useful therein |
| 04/24/2008 | WO2007070599A3 Chemoprotective methods and compositions |
| 04/24/2008 | WO2007060342A3 Use of guanabenz and its derivatives for making drugs for treating cystic fibrosis and diseases related to a protein addressing deficiency in the cells |
| 04/24/2008 | WO2007032028A8 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 04/24/2008 | WO2007030721A9 Processes for the preparation of (3r,4s)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((s)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-azetidinone, an intermediate for the synthesis of ezetimibe |
| 04/24/2008 | WO2007014219A3 Measurement of gait dynamics and use of beta-blockers to detect, prognose, prevent and treat amyotrophic lateral sclerosis |
| 04/24/2008 | WO2007011874A3 Formulation and method for administration of ophthalmologically active agents |
| 04/24/2008 | WO2006130174A3 Compositions comrising nebivolol |
| 04/24/2008 | WO2006041934A3 Methods and compositions for improving recombinant protein production |
| 04/24/2008 | US20080097385 Therapeutic Adjuncts to Enhance the Organ Protective Effects of Postconditioning |
| 04/24/2008 | US20080097167 Assess patient's condition and adjusts the therapy; displaying real-time pharmacokinetics data associated with the quantity of anesthetic agent provided; safety control initiates when predetermined threshold value is detected by the monitor; detect ratio of anesthetic exhaled against inhaled |
| 04/24/2008 | US20080097119 preventing, treating or ameliorating retinoid poisoning, overdose by a retinoid; Z-4-[3-(3,3-Dimethyl-1-p-tolyl-3H-inden-5-yl)-3-hydroxyimino-propenyl]-3-fluoro-benzoic acid |
| 04/24/2008 | US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug |
| 04/24/2008 | US20080097109 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 04/24/2008 | US20080097105 Biphenyl-2-ylcarbamic Acid 1-{9-[2-(4-Hydroxy-2-oxo-2,3-dihydrobenzothiazol-7-yl)-ethylamino]nonyl}piperidin-4-yl Ester Bis(trifluoroacetate) Salt; chronic obstructive pulmonary disease, asthma; bronchodilators |